We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRE icon
151
CBRE Group
CBRE
$40.8B
$22.5M 0.13%
160,654
-11,634
-7% -$1.47M
GE icon
152
GE Aerospace
GE
$367B
$22.4M 0.13%
87,069
-58,521
-40% -$12.8M
TWLO icon
153
Twilio
TWLO
$29.1B
$21.9M 0.13%
176,453
+1,881
+1% +$200K
MET icon
154
MetLife
MET
$61B
$21.8M 0.13%
270,687
-95,048
-26% -$7.33M
IBM icon
155
IBM
IBM
$202B
$21.6M 0.12%
73,417
-44,012
-37% -$11.3M
BLK icon
156
Blackrock
BLK
$164B
$21.6M 0.12%
20,567
+8,337
+68% +$7.88M
PWR icon
157
Quanta Services
PWR
$93.9B
$21.3M 0.12%
56,358
+3,333
+6% +$1.07M
CSL icon
158
Carlisle Companies
CSL
$13.6B
$21M 0.12%
56,311
-20,965
-27% -$7.78M
INTU icon
159
Intuit
INTU
$81.1B
$20.6M 0.12%
26,183
+147
+0.6% +$99.5K
AEM icon
160
Agnico Eagle Mines
AEM
$72.6B
$20.5M 0.12%
172,718
+152,762
+765% +$17.7M
BIIB icon
161
Biogen
BIIB
$29.9B
$20.5M 0.12%
163,315
-23,465
-13% -$2.92M
VRNA
162
DELISTED
Verona Pharma
VRNA
$20.5M 0.12%
216,400
-81,355
-27% -$6.02M
LH icon
163
Labcorp
LH
$24.3B
$20.2M 0.12%
76,838
-262
-0.3% -$63.8K
MFC icon
164
Manulife Financial
MFC
$72.6B
$20M 0.12%
626,180
+73,553
+13% +$2.27M
CRNX icon
165
Crinetics Pharmaceuticals
CRNX
$8.86B
$20M 0.12%
693,869
+204,958
+42% +$6.33M
VTR icon
166
Ventas
VTR
$48.9B
$19.9M 0.11%
315,400
+271,734
+622% +$17.7M
CGON icon
167
CG Oncology
CGON
$6.11B
$19.9M 0.11%
+763,580
New +$18.4M
RYTM icon
168
Rhythm Pharmaceuticals
RYTM
$7B
$19.7M 0.11%
312,452
+20,983
+7% +$1.28M
TXN icon
169
Texas Instruments
TXN
$255B
$19.4M 0.11%
93,502
-94,157
-50% -$16.7M
IDYA icon
170
IDEAYA Biosciences
IDYA
$3.41B
$19.2M 0.11%
914,400
-23,777
-3% -$456K
FCX icon
171
Freeport-McMoran
FCX
$90B
$19.2M 0.11%
442,965
+202,568
+84% +$7.69M
KLAC icon
172
KLA
KLAC
$275B
$19.1M 0.11%
213,760
-78,220
-27% -$5.88M
RARE icon
173
Ultragenyx Pharmaceutical
RARE
$2.65B
$19.1M 0.11%
526,267
-201,750
-28% -$7.27M
SHW icon
174
Sherwin-Williams
SHW
$78.3B
$19.1M 0.11%
55,695
-915
-2% -$317K
C icon
175
Citigroup
C
$222B
$19.1M 0.11%
224,602
+5,827
+3% +$421K

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.